Insider Transactions in Q1 2025 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
551
-2.11%
|
$18,734
$34.3 P/Share
|
|
Mar 07
2025
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,139
+4.17%
|
-
|
|
Mar 03
2025
|
Paul Sagan Director |
BUY
Open market or private purchase
|
Indirect |
31,620
+9.2%
|
$980,220
$31.76 P/Share
|
|
Mar 03
2025
|
Stephane Bancel Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
160,314
+0.87%
|
$4,969,734
$31.29 P/Share
|
|
Feb 28
2025
|
James M Mock Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-1.06%
|
$4,960
$31.09 P/Share
|
|
Feb 28
2025
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
329
+2.14%
|
-
|
|
Feb 28
2025
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-0.54%
|
$8,463
$31.09 P/Share
|
|
Feb 28
2025
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+1.11%
|
-
|
|
Feb 28
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
612
-0.02%
|
$18,972
$31.09 P/Share
|
|
Feb 28
2025
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,263
+0.04%
|
-
|
|
Feb 27
2025
|
James M Mock Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-6.25%
|
$91,740
$33.58 P/Share
|
|
Feb 27
2025
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,746
+11.26%
|
-
|
|
Feb 27
2025
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,779
-5.47%
|
$91,707
$33.58 P/Share
|
|
Feb 27
2025
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,747
+10.16%
|
-
|
|
Feb 27
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,779
-0.19%
|
$91,707
$33.58 P/Share
|
|
Feb 27
2025
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,746
+0.39%
|
-
|
|
Feb 12
2025
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,068
-4.75%
|
$32,040
$30.93 P/Share
|
|
Feb 12
2025
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,047
+8.34%
|
-
|
|
Feb 12
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,771
-0.19%
|
$83,130
$30.93 P/Share
|
|
Feb 12
2025
|
Stephen Hoge President |
BUY
Grant, award, or other acquisition
|
Direct |
5,734
+0.39%
|
-
|
|
Feb 12
2025
|
Stephane Bancel Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,400
-0.12%
|
$192,000
$30.93 P/Share
|
|
Feb 12
2025
|
Stephane Bancel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,233
+0.24%
|
-
|
|
Feb 07
2025
|
Stephen Hoge President |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-0.02%
|
$9,273
$33.61 P/Share
|
|
Feb 07
2025
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
523
+0.04%
|
-
|
|
Jan 03
2025
|
James M Mock Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-6.23%
|
$32,760
$42.0 P/Share
|
|
Jan 03
2025
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,453
+10.4%
|
-
|